Creative Financial Designs’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.7K Sell
199
-22
-10% -$4.14K ﹤0.01% 1098
2026
Q1
$43.6K Buy
221
+57
+35% +$11K ﹤0.01% 940
2025
Q4
$30.1K Hold
164
﹤0.01% 1041
2025
Q3
$25.1K Buy
164
+10
+6% +$1.51K ﹤0.01% 1079
2025
Q2
$21.5K Buy
154
+4
+3% +$561 ﹤0.01% 1117
2025
Q1
$22K Buy
150
+123
+456% +$17.8K ﹤0.01% 1058
2024
Q4
$3.47K Hold
27
﹤0.01% 1495
2024
Q3
$4.13K Hold
27
﹤0.01% 1422
2024
Q2
$4.13K Hold
27
﹤0.01% 1359
2024
Q1
$3.59K Hold
27
﹤0.01% 1379
2023
Q4
$3.57K Hold
27
﹤0.01% 1328
2023
Q3
$3.59K Buy
+27
New +$3.69K ﹤0.01% 1251
2022
Q2
Sell
-47
Closed -$6K 1238
2022
Q1
$6K Buy
+47
New +$5.64K ﹤0.01% 996
2021
Q4
Sell
-308
Closed -$37K 1218
2021
Q3
$37K Buy
308
+266
+633% +$31K 0.01% 683
2021
Q2
$5K Hold
42
﹤0.01% 1156
2021
Q1
$4K Hold
42
﹤0.01% 1084
2020
Q4
$4K Sell
42
-89
-68% -$9.43K ﹤0.01% 1010
2020
Q3
$14K Buy
131
+39
+42% +$4.34K ﹤0.01% 729
2020
Q2
$10K Buy
+92
New +$9.5K ﹤0.01% 745
2017
Q3
Sell
-250
Closed -$17K 738
2017
Q2
$17K Hold
250
0.01% 342
2017
Q1
$16K Hold
250
0.01% 344
2016
Q4
$14K Buy
+250
New +$14.2K 0.01% 354

Other funds holding AZN

Creative Financial Designs's AZN Position: Q2 2026 in Review

Creative Financial Designs reduced its AstraZeneca (AZN) stake by 10% in Q2 2026, selling an estimated $4.14K and leaving 199 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Creative Financial Designs first reported a position in AZN in Q4 2016 and has held it in 22 quarters since. The position peaked at $43.6K in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Creative Financial Designs held 199 shares of AstraZeneca worth $37.7K as of Q2 2026.
  • Creative Financial Designs sold 22 AstraZeneca shares in Q2 2026, an estimated $4.14K.
  • AstraZeneca made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1098 holding.
  • Creative Financial Designs first reported a position in AstraZeneca in Q4 2016 and has held it in 22 quarters since.
  • Creative Financial Designs's AstraZeneca position peaked at $43.6K in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.